✦ LIBER ✦

Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors

✍ Scribed by Wakui, Hiroshi; Yamamoto, Noboru; Nakamichi, Shinji; Tamura, Yousuke; Nokihara, Hiroshi; Yamada, Yasuhide; Tamura, Tomohide

Book ID: 121544939
Publisher: Springer
Year: 2014
Tongue: English
Weight: 341 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2375-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

234 A phase 1, open-label, dose-finding

234 A phase 1, open-label, dose-finding study to assess the safety and tolerability of U3 1287 (AMG 888), a human monoclonal antibody targeting HER3 in patients with advanced solid tumors

✍ P. LoRusso; V. Keedy; L. Yee; M. Oliveira; N. Rizvi; J. Berlin; X. Jin; T. Hettm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A phase 1 and dose-finding study of LY25

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors

✍ Wakui, Hiroshi; Yamamoto, Noboru; Kitazono, Satoru; Mizugaki, Hidenori; Nakamich 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 366 KB

A Phase I, dose-finding and pharmacokine

A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors

✍ Noboru Yamamoto; Hiroshi Nokihara; Yasuhide Yamada; Yasushi Goto; Maki Tanioka; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Safety and tolerability of AZD8055 in Ja

Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study

✍ Asahina, Hajime; Nokihara, Hiroshi; Yamamoto, Noboru; Yamada, Yasuhide; Tamura, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 317 KB

Phase I, dose-finding study of AZD8931,

Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors

✍ Tjulandin, S.; Moiseyenko, V.; Semiglazov, V.; Manikhas, G.; Learoyd, M.; Saunde 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 313 KB

Phase I Safety and Pharmacokinetic Study

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 346 KB